Search Results - "Benitez‐Ribas, D."

Dendritic cells phenotype fitting under hypoxia or lipopolysaccharide; adenosine 5′‐triphosphate‐binding cassette transporters far beyond an efflux pump by Lloberas, N., Rama, I., Llaudó, I., Torras, J., Cerezo, G., Cassis, L., Franquesa, M., Merino, A., Benitez‐Ribas, D., Cruzado, J. M., Herrero‐Fresneda, I., Bestard, O., Grinyó, J. M.

“…Summary This study examines adenosine 5′‐triphosphate‐binding cassette (ABC) transporters as a potential therapeutic target in dendritic cell (DC) modulation…”
Get full text

Cellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatment by Rodríguez Pérez, Á., Campillo-Davo, D., Van Tendeloo, V. F. I., Benítez-Ribas, D.

“…Cancer immunotherapy has opened a new chapter in Medical Oncology. Many novel therapies are under clinical testing and some have already been approved and…”
Get full text

AVEVAC: A phase I-II trial with avelumab plus autologous dendritic cell (ADC) vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer (mCRC) patients (GEMCAD 16-02) by Español Rego, M., Alonso, V., Aparicio, J., Elez Fernandez, E., Escudero, P., Fernández-Martos, C., Rodríguez, N., Ruiz Casado, A., Cid, J., Cabezón, R., Lozano, M., Ginés, A., Bianchi, L., Garcia-Corbacho, J., García de Albéniz, X., Maurel, J., Benitez Ribas, D.

Get full text

P862: SERUM MASS SPECTROMETRY TO ANALYZE DISEASE RESPONSE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ARI0002H, AN ACADEMIC BCMA‐DIRECTED CAR T‐CELL THERAPY by Ortiz De Landazuri, I., Oliver‐Caldés, A., Español‐Rego, M., Contreras, M. T., Zabaleta, A., Agulló, C., Puig, N., Cabañas, V., González‐Calle, V., Jiménez, R., Inogés, S., Rodríguez‐Otero, P., Martin‐Antonio, B., Reguera, J. L., López‐Diaz de Cerio, A., Benítez‐Ribas, D., Rodríguez‐Lobato, L. G., González, E. A., Rosiñol, L., Yagüe, J., Moraleda, J. M., Urbano‐Ispizua, Á., Mateos, M. V., Juan, M., Paiva, B., Pascal, M., Fernández de Larrea, C.

Get full text

SO-26 In-silico Lynch syndrome-related neoantigens prediction for a dendritic cell-based cancer prevention vaccine by Bayó, C., Castellano, G., Ocaña, T., Moreira, L., Carballal, S., Sánchez, A., Moreira, R., Ortiz, O., Castells, A., Pellisé, M., Juan-Otero, M., Benitez-Ribas, D., Balaguer, F.

Get full text

611TiPAVEVAC: A phase I-II trial with avelumab plus autologous dendritic cell (ADC) vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer (mCRC) patients (GEMCAD 16-02) by Español Rego, M, Alonso, V, Aparicio, J, Elez Fernandez, E, Escudero, P, Fernández-Martos, C, Rodríguez, N, Ruiz Casado, A, Cid, J, Cabezón, R, Lozano, M, Ginés, A, Bianchi, L, Garcia-Corbacho, J, García de Albéniz, X, Maurel, J, Benitez Ribas, D

Get full text

Mesenchymal stem cell therapy of Crohn's disease: are the far-away hills getting closer? by Panés, Julián, Benitez-Ribas, Daniel, Salas, Azucena

Get more information

Evaluation of central nervous system involvement in patients undergoing chimeric antigen receptor-engineered T-cell therapy by magnetic resonance imaging by Choque-Chávez, F.D., Jareño-Badenas, A., Benítez-Ribas, D., Oleaga, L.

Get full text

996P An immune-metabolic signature correlates with immune-suppressive patterns and with outcome, across tumor types by Pedrosa, L., Foguet, C., Oliveres, H., Archilla, I., García de Herreros, M., Rodriguez, A., Postigo, A., Benítez-Ribas, D., Camps, J., Cuatrecasas, M., Castells, A., Prat, A., Thomson, T.M., Maurel, J., Cascante, M.

Get full text

442P A phase I-II multicenter trial with avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients. GEMCAD 16-02 (AVEVAC trial) by Español-Rego, M., Fernández-Martos, C., Fernandez, M.E. Elez, Foguet, C., Pedrosa, L., Rodríguez, N., Ruiz, A., Pineda, E., Cid, J., Cabezón, R., Oliveres, H., Lozano, M., Ginés, A., Garcia-Criado, A., Cuatrecasas, M., Torres, F., Cascante, M., Benítez-Ribas, D., Maurel, J.

Get full text